Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity

from Biologic Therapy In Rheumatoid Arthritis · host Rheumatology News International

Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Professor VonVollenhoven also discusses recent research on the role of biologic markers for RA.

Episode metadata supplied by the publisher feed · Published Dec 5, 2008

Embed this episode

Attribution link and audio player

What this episode covers

Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity

0:00 14:21

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Biologic Therapy In Rheumatoid Arthritis?

This episode is 14 minutes long.

When was this Biologic Therapy In Rheumatoid Arthritis episode published?

This episode was published on December 5, 2008.

Can I download this Biologic Therapy In Rheumatoid Arthritis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!